ACAD
32.59
-0.76
-2.28%
AEMD
0.227
-0.013
-5.417%
APRI
1.87
-0.05
-2.60%
ARNA
4.37
-0.11
-2.46%
ATEC
1.45
+0.04
+2.84%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.18
-0.02
-1.67%
DXCM
62.34
+0.36
+0.58%
GNMK
12.98
-0.32
-2.41%
HALO
14.28
+0.28
+2.00%
ILMN
185.64
-1.98
-1.06%
INNV
0.14
-0.04
-21.74%
INO
8.16
-0.17
-2.04%
ISCO
0.058
-0.001
-1.1966%
ISIS
63.67
-1.14
-1.76%
LGND
77.11
+0.88
+1.15%
LPTN
2.47
0.00
0.00%
MBVX
1.87
+0.01
+0.54%
MEIP
1.79
+0.04
+2.29%
MNOV
3.5
-0.09
-2.51%
MRTX
29.32
+0.21
+0.72%
MSTX
0.485
-0.012
-2.513%
NBIX
39.71
-1.82
-4.38%
NUVA
45.99
-0.41
-0.88%
ONCS
0.335
-0.015
-4.286%
ONVO
3.54
+0.17
+5.04%
OREX
7.83
+0.08
+1.03%
OTIC
35.36
-0.27
-0.76%
QDEL
26.98
-0.52
-1.89%
RCPT
164.89
+4.84
+3.02%
RGLS
16.94
-0.32
-1.85%
RMD
71.78
+0.13
+0.18%
SCIE
0.03
0.00
+17.65%
SPHS
0.579
+0.029
+5.2545%
SRNE
11.56
+0.2
+1.76%
TROV
6.81
-0.19
-2.71%
VICL
0.945
+0.045
+4.9889%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
0.00
0.00%
ACAD
32.59
-0.76
-2.28%
AEMD
0.227
-0.013
-5.417%
APRI
1.87
-0.05
-2.60%
ARNA
4.37
-0.11
-2.46%
ATEC
1.45
+0.04
+2.84%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.18
-0.02
-1.67%
DXCM
62.34
+0.36
+0.58%
GNMK
12.98
-0.32
-2.41%
HALO
14.28
+0.28
+2.00%
ILMN
185.64
-1.98
-1.06%
INNV
0.14
-0.04
-21.74%
INO
8.16
-0.17
-2.04%
ISCO
0.058
-0.001
-1.1966%
ISIS
63.67
-1.14
-1.76%
LGND
77.11
+0.88
+1.15%
LPTN
2.47
0.00
0.00%
MBVX
1.87
+0.01
+0.54%
MEIP
1.79
+0.04
+2.29%
MNOV
3.5
-0.09
-2.51%
MRTX
29.32
+0.21
+0.72%
MSTX
0.485
-0.012
-2.513%
NBIX
39.71
-1.82
-4.38%
NUVA
45.99
-0.41
-0.88%
ONCS
0.335
-0.015
-4.286%
ONVO
3.54
+0.17
+5.04%
OREX
7.83
+0.08
+1.03%
OTIC
35.36
-0.27
-0.76%
QDEL
26.98
-0.52
-1.89%
RCPT
164.89
+4.84
+3.02%
RGLS
16.94
-0.32
-1.85%
RMD
71.78
+0.13
+0.18%
SCIE
0.03
0.00
+17.65%
SPHS
0.579
+0.029
+5.2545%
SRNE
11.56
+0.2
+1.76%
TROV
6.81
-0.19
-2.71%
VICL
0.945
+0.045
+4.9889%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
0.00
0.00%
Home » Bio: David Webb, Ph.D.

Bio: David Webb, Ph.D.

Dr. Webb joined Celgene-San Diego in September, 2003 as Vice President, Research where he is now Site Head and Vice President of Research with responsibility for Chemistry and Alliance Development. Between 1995 and 2003, he held a series of VP level management positions in several biotechnology companies where he developed and led drug discovery programs focused on inflammation, asthma, cancer and diabetes.
From 1987 to 1995, Dr. Webb was at Syntex, Inc where he held the positions of Distinguished Scientist and Director, Institute of Immunology and Biological Sciences; in addition he was Consulting Professor of Cancer Biology at Stanford University. Dr. Webb was a member of the Department of Cell Biology at the Roche Institute of Molecular Biology from 1973 to 1987 and was Adjunct Professor of Human Genetics at Columbia University College of Physicians and Surgeons, as well as Adjunct Professor at Rutgers University. He has published over 200 peer reviewed publications and abstracts and has served on numerous editorial boards in the field of Immunology. In addition he has been a member of Study Sections for NSF, ACS, NIH and the VA. Dr. Webb received his Ph.D. from Rutgers University and was a Dernham Junior Fellow in Cancer Research at UCSF before joining the Roche Institute.